Experiences with

Ramucirumab

On May 29th, 2020, the Food and Drug Administration (FDA) approved the combination of Cyramza (ramucirumab) and Tarceva (erlotinib) for the first line treatment of advanced non-small cell lung cancer (NSCLC) with tumors having changes in EGFR called exon 19 deletions or exon 21 L858R mutations.

The hospital my dad will receive treatment (Docetaxel and Ramucirumab) at for stage IV NSCLC does not have cooling caps available. Is there an option to bring and set up your own system each time? Any advice is much appreciated. Thanks!

Last April, after progression on Carbo/Alimta and Alimta maintenance, I started Docetaxel (Taxotere) and Ramucirumab (Cyramza) as second line and I’ve been stable since last August.

Now the new plan is docetaxel and ramucirumab this will now be a 4 hour infusion. This will now be harder than carboplatin and alimta. Really scared...... they say I will lose my hair just when it finally came back. Plus a host of other side effects.

Happy New year! Well I just left my oncologist and he is switching my chemo because the carboplatin and Gemzar arent working. Has anyone had any experience with these two drugs we are switching to? I understand I will lose my hair this time.